 Carl Icahn |
Sard Verbinnen & Co. represents SandRidge Energy as it adopts a “poison pill” provision to head off a potential raid by activist Carl Icahn, who has knocked its $750M proposal to acquire Bonanza Energy.
Owner of a 13.5 percent stake in SandRidge, Icahn has blasted the Bonanza deal as “nonsensical.” In last week's federal filing, he questioned management's "possible justifications" for the deal.
The poison pill precludes any investor from acquiring more than a 10 percent stake in the Oklahoma-based company and "grandfathers in" current investors.
SandRidge chairman John Genova called the poison pill, which expires a year from now, a short-term move to protect shareholder rights to vote on the merger plan with Bonanza.
The rights plan is “designed to deter the acquisition of actual, de facto or negative control of the company by any person or group without appropriately compensating its shareholders for such control,” according to SandRidge’s Nov. 27 statement.
SV&C’s Bryan Locke and Kelly Kimberly handle media for SandRidge.
Edelman handles Viking Holdings, the river and ocean luxury cruise line that plans to raise $1B via an IPO priced in the $21 to $25 per share range.
Teneo is handling the initial public offering of CVC Capital Partners, one of Europe’s largest private equity firms with nearly $200B in assets under management.
Brunswick Group represents Endeavor Group Holdings as it agrees to go private via its acquisition by Silver Lake technology investment firm, which is handled by Edelman Smithfield.
Tod Donhauser, a nine-year veteran of Edelman, has joined H/Advisors Abernathy as managing director and head of its San Francisco office.
Intelligent Group Ltd, a Hong Kong-based financial PR firm, has priced its initial public offering of 1.9M shares at $4, which is the low end of the $4 to $5 range.
Have a comment? Send it to 
No comments have been submitted for this story yet.